NCT03682172View on ClinicalTrials.gov

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

August 30, 2018

Study Completion Date

July 1, 2020

Conditions
Effect of Glucagon-like Peptide 2 on Gallbladder Motility
Interventions
DRUG

GLP-2 (1pmol/kg/min)

Four hour intravenous infusion with glucagon-like peptide 2 at a rate of 1pmol/kg/min

DRUG

GLP-2 (10pmol/kg/min)

Four hour intravenous infusion with glucagon-like peptide 2 at a rate of 10 pmol/kg/min

DRUG

Placebo

Four hour intravenous infusion with saline water

Trial Locations (1)

2900

Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen, Hellerup

All Listed Sponsors
lead

Steno Diabetes Center Copenhagen

OTHER

NCT03682172 - Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects | Biotech Hunter | Biotech Hunter